Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

2015/06/06 by Amirhossein Sahebkar, Kazuhiko Kotani, Corina Serban +11 · 25 citations
Medicine · #Nitric Oxide and Endothelin Effects #Cardiovascular Health and Disease Prevention #Pulmonary Hypertension Research and Treatments

paper · doi:10.1016/j.atherosclerosis.2015.05.022

Citations

• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

Cited by

• Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials. [europepmc]
• Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate. [europepmc]
• Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials. [europepmc]
• Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies. [europepmc]
• Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. [europepmc]
• Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. [europepmc]
• The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu. [europepmc]
• Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. [europepmc]
• The effects of statins on dental and oral health: a review of preclinical and clinical studies. [europepmc]
• Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways. [europepmc]
• Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic. [europepmc]
• Statins and the COVID-19 main protease: in silico evidence on direct interaction. [europepmc]
• Cholesterol in Relation to COVID-19: Should We Care about It? [europepmc]
• Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. [europepmc]
• Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. [europepmc]
• Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation. [europepmc]
• Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin. [europepmc]
• Statins and C-reactive protein: in silico evidence on direct interaction. [europepmc]
• In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis. [europepmc]
• Beneficial Effect of Statin Therapy on Arterial Stiffness. [europepmc]
• Hydrophilic or Lipophilic Statins? [europepmc]
• Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [europepmc]
• Contrast-induced acute kidney injury and its contemporary prevention. [europepmc]
• Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations. [europepmc]
• Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review. [europepmc]